“BOSTON -Mark Andermann, PhD, a neuroendocrinology investigator at Beth Israel Deaconess Medical Center (BIDMC), has been awarded a prestigious Director’s New Innovator award as part of the High Risk-High Reward grant program sponsored by the National Institute of Diabetes and Digestive and Kidney Disorders (NIDDK) and the National Institutes of Health (NIH) Common Fund...”